Anagenics Ltd has released a press release.
Appendix 4C - quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Anagenics
- Cellmid signs distribution agreement for fillerina
- Appendix 4D and Half Year Accounts
- Record 2M sales for cellmid FGF5 inhibitors
- Cellmid quarterly operational update
- Cellmid placement to strategic investor
Later from Anagenics
- Cellmid secures bloomingdales usa partnership for evolis
- Cellmid to commence selling of evolis into chinese market
- Cellmid updates on distribution of evolis
- Cellmid Share Placement Raises $9M
- Cellmid Share Purchase Plan
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics